Bioscience

Arizona Board of Regents approves new cancer prevention company

February 3, 2009

By Flinn Foundation

[Source: BIO5] – The Arizona Board of Regents gave approval for a UA researcher to take on part ownership of the new Tucson company Cancer Prevention Pharmaceuticals (CPP). CPP’s work may one day help prevent colon cancer in those at high risk for the disease. UA Professor of Cell Biology and Anatomy Eugene Gerner will run CPP with his colleague Frank L. Meyskens, Jr., Professor of Medicine and Director of the Chao Family Comprehensive Cancer Center at the University of California in Irvine. Gerner is a member of UA’s BIO5 Institute and the Arizona Cancer Center.

For more information click here.